These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31578261)

  • 1. Implication of Broadly Neutralizing Bovine Monoclonal Antibodies in the Development of an Enzyme-Linked Immunosorbent Assay for Detecting Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype O.
    Cao Y; Li K; Wang S; Fu Y; Sun P; Li P; Bai X; Zhang J; Ma X; Xing X; Zhou S; Bao H; Li D; Chen Y; Li Z; Lu Z; Liu Z
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31578261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Competitive ELISA Based on Bovine Monoclonal Antibodies for the Detection of Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype A.
    Cao Y; Li K; Xing X; Zhu G; Fu Y; Bao H; Bai X; Sun P; Li P; Zhang J; Ma X; Wang J; Zhao Z; Li D; Liu Z; Lu Z
    J Clin Microbiol; 2022 Apr; 60(4):e0214221. PubMed ID: 35254106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Cross-Protective Antigen Sites on Foot-and-Mouth Disease Virus Serotype O Structurally Revealed by Broadly Neutralizing Antibodies from Cattle.
    Li K; He Y; Wang L; Li P; Wang S; Sun P; Bao H; Cao Y; Liu X; Zhu G; Song Y; Bai X; Ma X; Fu Y; Yuan H; Zhang J; Wang J; Chen Y; Li D; Lou Z; Liu Z; Lu Z
    J Virol; 2021 Oct; 95(21):e0088121. PubMed ID: 34406868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of mAbs to foot-and-mouth disease virus serotype A and application in a competitive ELISA for serodiagnosis.
    Yang M; Xu W; Bittner H; Horsington J; Vosloo W; Goolia M; Lusansky D; Nfon C
    Virol J; 2016 Nov; 13(1):195. PubMed ID: 27894355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.
    Yang M; Xu W; Goolia M; Zhang Z
    Virol J; 2014 Aug; 11():136. PubMed ID: 25085313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
    Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the immunological response elicited by a polyvalent foot and mouth disease vaccine and its compatibility with a diva test in Jimma Town, Ethiopia.
    Tegegne H; Ejigu E; Woldegiorgis D
    Virol J; 2024 Oct; 21(1):250. PubMed ID: 39375730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect ELISA using a multi-epitope recombinant protein to detect antibodies against foot-and-mouth disease virus serotype O in pigs.
    Cao Y; Zhou W; Xing X; Zhang J; Fu Y; Li K; Sun P; Li P; Bai X; Ma X; Bao H; Li D; Chen Y; Lu Z; Liu Z
    J Virol Methods; 2018 Dec; 262():26-31. PubMed ID: 30244034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle.
    Lavoria MÁ; Di-Giacomo S; Bucafusco D; Franco-Mahecha OL; Pérez-Filgueira DM; Capozzo AV
    Vaccine; 2012 Nov; 30(48):6845-50. PubMed ID: 23000129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
    Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
    Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus serotype Asia 1.
    Ko YJ; Jeoung HY; Lee HS; Chang BS; Hong SM; Heo EJ; Lee KN; Joo HD; Kim SM; Park JH; Kweon CH
    J Virol Methods; 2009 Jul; 159(1):112-8. PubMed ID: 19442854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a competitive ELISA based on bacterium-original virus-like particles of serotype O foot-and-mouth disease virus for detecting serum antibodies.
    Ran X; Yang Z; Bai M; Zhang Y; Wen X; Guo H; Sun S
    Appl Microbiol Biotechnol; 2019 Apr; 103(7):3015-3024. PubMed ID: 30783719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing monoclonal antibody sandwich liquid-phase blocking enzyme-linked immunosorbent assay for detection of Foot-and-mouth disease virus type O antibodies.
    Morioka K; Fukai K; Yoshida K; Yamazoe R; Onozato H; Ohashi S; Tsuda T; Sakamoto K
    J Vet Diagn Invest; 2009 Jul; 21(4):499-503. PubMed ID: 19564498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Clin Vaccine Immunol; 2014 May; 21(5):674-83. PubMed ID: 24623625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures of Foot-and-Mouth Disease Virus with Bovine Neutralizing Antibodies Reveal the Determinant of Intraserotype Cross-Neutralization.
    He Y; Li K; Wang L; Sun Z; Cao Y; Li P; Sun P; Bao H; Zhou S; Wang S; Bai X; Liu X; Zhao L; Fan X; Liu Z; Lu Z; Yang C; Lou Z
    J Virol; 2021 Nov; 95(24):e0130821. PubMed ID: 34586859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.